A powerful psychedelic that is used in healing ceremonies by Indigenous groups in the Amazon is being trialled as a pioneering approach to reduce problematic alcohol consumption.
Dimethyltryptamine (DMT) is the active ingredient in ayahuasca, a hallucinogenic brew that has been used for thousands of years by shamans in South America. Scientists based at University College London are testing whether a one-off dose of the drug could help hazardous drinkers who want to reduce their alcohol intake.